Jia et al [41] investigated the expression levels of serum HIF-1α and VEGF pre- and post-TACE in patients with HCC, and correlations between prognosis factors and serum HIF-1α as well as VEGF levels. Here, VEGFA is linked to hepatocellular carcinoma.